Skip to main content

Showing results for Cancer

What's Next in the Fight Against Myeloma?

IU School of Medicine recruited leading researchers and is studying how a patient’s personal factors and environment play a role in the disease.

Bobby King  |  Apr 09, 2020

Going the Extra Mile

Rafat Abonour’s commitment to curing multiple myeloma is unwavering. Each year, he leads a ride for a cure—a ritual that binds him closer to the patients he has lost and those he is trying to save.

Bobby King  |  Apr 08, 2020

After Early Success, IU Poised to Grow CAR T Program

The Tilley family’s experience shows the life-saving potential of immunotherapy—and underscores why Indiana University School of Medicine wants to scale up its staff to treat more patients.

Why Does Kathy Miller Hate Pink?

For the breast cancer researcher, the color reminds her of the work IU School of Medicine still must do to turn breakthroughs in the lab into treatments for patients.

Katie Duffey  |  Jan 06, 2020

Rebuilding Health

VICTOR RIGDON CAN fix just about anything. A carpenter at the Indiana State Fairgrounds, he repairs buildings, restores benches and flower boxes—anything. But three years ago, Rigdon found something he couldn’t fix.  His cough. Rigdon didn’t hack. He didn’t ache. It was just a light cough. When he left a walk-in medical clinic with a prescription for antibiotics, Rigdon figured the cough would soon be gone.  Ten days later, Rigdon sat in an exam room and stared as his physician […]

Riding for Life

As a boy, Greg Tamer saw what multiple myeloma did to his father. He would learn how far science has come – and how far it must still go – only after being diagnosed with the same disease 55 years later. He’s counting on research to find a cure, and Indiana University School of Medicine is leading the way. Watch Greg’s story. To learn more about multiple myeloma research at IU School of Medicine, contact Lizzie Conkle at econkle@iu.edu or […]

Coupled in the Fight Against Cancer

XIONGBIN LU, PhD, spends his days engrossed in research into the factors that lead normal breast tissue cells to turn into Triple Negative Breast Cancer—and engineering therapies to stop it. Across the hall from Lu’s lab, Xinna Zhang, PhD, dives deeply into her the study of the biology of HER2-positive breast cancer, and what makes cells resistant to drug therapies. But Lu and Zhang share more than their proximity to one another in the Vera Bradley Foundation Breast Cancer Research […]

Truly Healed

THE PAIN pulsing in James Mikesh’s lower back was so bad it shook him from his sleep. When it hit, Mikesh—then a senior at the University of Minnesota—would trudge into his bathroom, turn on the knobs in his bathtub and slip into warm water, searching for relief. For a while, that was enough. Then the pain spread to his groin, and Mikesh sought help. It took little time for an oncologist to diagnose the problem: Testicular cancer, stage 3. At […]

In Elite Company

FROM HIS days as a medical student to his current post as director, Patrick Loehrer has been a witness to and a leader in the rise of the Indiana University Melvin and Bren Simon Cancer Center. And so, after the National Cancer Institute bestowed its highest recognition upon the center—comprehensive cancer center status—Loehrer stood in August before an audience gathered to celebrate the achievement, and briefly recounted some of that history. He spoke of Larry Einhorn developing his revolutionary treatment […]

Detonating Cancer

IN THE fight against one of the most aggressive forms of breast cancer, an Indiana University School of Medicine researcher is refining what he hopes will be a weapon as deadly as its foe—a “nanobomb.” Xiongbin Lu, PhD, the Vera Bradley Foundation Professor of Breast Cancer Innovation, is working on a microscopic cancer-fighting tool that—in its assault on triple negative breast cancer cells—acts almost like a Trojan horse, but with an explosive twist.  Lu’s nanobomb is a pair of cancer […]